BioLineRx Ltd.

Regulatory Filings • Sep 23, 2016

_________ false

������� �� ��� ��"�	2 381
BIOLINE RX LTD
Corporation no: 513398750	9253
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	23/09/2016
	www.isa.gov.il			www.tase.co.il				Reference:	2016-02-127915	Time of broadcast: 13:51 13:44:53

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under Strategic Collaboration

6-K_BL-1220_230916_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 26/07/2016
Address: HaMa'ayan 2 , Modi'in 7177871   , Israel Tel: 08-6429100 , Fax: 08-6429101
E-mail address: info@BioLineRx.com   Company site: www.biolinerx.com
Previous names of reporting entity:
Name of the Signatory: Kotler Norman Harold Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company:
Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: normank@biolinerx.com 1
Israel